Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
When youre ready, were here to help.
For lupus nephritis patients, who face heightened risks of heart and kidney failure, GLP-1 receptor agonists could offer a much-needed lifeline
Projected Timeline (Estimates, Not Confirmed) Phase 3 completion: Most TRIUMPH trials completing throughout 2026 NDA submission to FDA: Estimated late 2026 (depends on results across the full program) FDA review period: Typically 10-12 months for a standard review Approval decision: Estimated 2027, possibly earlier if Lilly seeks priority review Commercial availability (pharmacies): Several months after approval for manufacturing scale-up GlobalData, a pharmaceutical analytics firm, projects a 2027 approval with forecasted annual sales reaching $15.6 billion by 2031
They may be used as a standalone therapy for metabolic control or paired with traditional treatments to create a more comprehensive plan
doi: 10.3390/nu13010183 55 XiaMFChenLYWuLMaHLiXMLiQet al
Multidose vials like compounded semaglutide are generally considered safe to use for up to 28 days after they are first punctured or opened when stored in the fridge or at a controlled temperature
